Mitchell, P L R <br/><br/>
A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Apr 2004 
 - 585-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdh144  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Colony-Forming Units Assay<br/>Docetaxel<br/>Drug Therapy, Combination<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Taxoids--adverse effects<br/>Treatment Outcome